We are live on ! Find out more
KRON

Kronos Bio
KRON

Delisted

KRON was delisted on the 20th of June, 2025.

Back to rankings

97 hedge funds and large institutions have $56.3M invested in Kronos Bio in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 24 increasing their positions, 32 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more funds holding

Funds holding: 96 → 97 (+1)

6% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 16

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

2.9% less ownership

Funds ownership: 63.54% → 60.64% (-2.9%)

25% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 32

53% less capital invested

Capital invested by funds: $121M → $56.3M (-$64.6M)

Holders
97
Holders Change
+1
Holders Change %
+1.04%
% of All Funds
1.56%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
24
Reduced
32
Closed
16
Calls
$21K
Puts
–
Net Calls
+$21K
Net Calls Change
+$19K

Top Buyers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
+$659K
2
Morgan Stanley
Morgan Stanley
New York
+$493K
3
BCM
Bridgeway Capital Management
Texas
+$460K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$454K
5
Millennium Management
Millennium Management
New York
+$443K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.03M
2
PA
Perceptive Advisors
New York
-$929K
3
BBA
Baker Bros. Advisors
New York
-$786K
4
PFMU
Privium Fund Management (UK)
United Kingdom
-$635K
5
BlackRock
BlackRock
New York
-$597K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
76
UBS Group
Switzerland
$17.7K +$25.1K +10,891 +32,032%
Mariner
77
Mariner
Kansas
$17K +$24.1K +10,487 New
CSS
78
Cubist Systematic Strategies
Connecticut
$14.3K -$50.9K -22,101 -72%
Royal Bank of Canada
79
Royal Bank of Canada
Ontario, Canada
$9K -$11.6K -5,025 -47%
AB
80
Amalgamated Bank
New York
$8K – – –
AIP
81
Ameritas Investment Partners
Nebraska
$7K – – –
Legal & General Group
82
Legal & General Group
United Kingdom
$5.71K – – –
QT
83
Quantbot Technologies
New York
$4.2K -$3.45K -1,500 -37%
PMEF
84
Point72 Middle East FZE
United Arab Emirates
$3.49K +$4.95K +2,152 New
DCBT
85
Dakota Community Bank & Trust
North Dakota
$2K – – –
Carson Wealth (CWM LLC)
86
Carson Wealth (CWM LLC)
Nebraska
$2K +$2.47K +1,072 New
RTL
87
Red Tortoise LLC
Georgia
$1.72K +$2.44K +1,062 New
Citigroup
88
Citigroup
New York
$1.4K -$704 -306 -26%
EI
89
Ellevest Inc
New York
$970 +$937 +407 +212%
BAM
90
Belpointe Asset Management
Nevada
$961 +$1.36K +593 New
FCA
91
Fortis Capital Advisors
Kansas
$961 +$1.36K +593 New
National Bank of Canada
92
National Bank of Canada
Quebec, Canada
$729 -$1.15K -500 -53%
AWM
93
Accurate Wealth Management
Florida
$223 +$226 +98 New
PA
94
Parallel Advisors
California
$162 +$230 +100 New
CS
95
Credit Suisse
Switzerland
$3 -$527 -229 -99%
HF
96
HRT Financial
New York
– -$273K -81,588 Closed
AA
97
ALPS Advisors
Colorado
– -$104K -31,034 Closed
MIM
98
MetLife Investment Management
New Jersey
– -$85.7K -25,568 Closed
SSA
99
Schonfeld Strategic Advisors
New York
– -$81K -24,300 Closed
AQR Capital Management
100
AQR Capital Management
Connecticut
– -$75K -22,524 Closed
1 2 3
4
5

KRON Hedge Fund Activity: Q4 2022 in Review

97 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Kronos Bio (KRON) for Q4 2022, worth a combined $56.3M — down 53% from $121M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new KRON positions and 16 closed out — a net gain of 1 holder — while 24 added to existing stakes and 32 trimmed.

The largest buyer was GSA Capital Partners, adding an estimated $659K. The largest seller was Fidelity Investments, cutting an estimated $2.03M.

  • 97 institutional investors held Kronos Bio (KRON) as of Q4 2022, up from 96 in Q3 2022.
  • Funds reported $56.3M of Kronos Bio stock for Q4 2022, down 53% quarter-over-quarter.
  • 17 funds opened new Kronos Bio positions in Q4 2022 and 16 closed out, a net change of +1 holder.
  • The largest Kronos Bio buyer in Q4 2022 was GSA Capital Partners, an estimated $659K added.
  • The largest Kronos Bio seller in Q4 2022 was Fidelity Investments, an estimated $2.03M sold.

Based on aggregated 13F filings for Q4 2022.